Related Experiment Video
Updated: May 20, 2026
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Semi-synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol derivatives
Peng Wang1, Xiu-Li Bi, Yu-Mei Guo
1School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, No.103 Wenhua Road, Shenyang 110016, PR China.
Abstract:
30 novel compounds have been synthesized from 25-hydroxyprotopanaxadiol (25-OH-PPD) and their in vitro anti-tumor activities were tested on three cancer cell lines and one normal cell line (IOSE144) by standard MTT assay. The results showed that compound 27 exhibited the best anti-tumor activity in the in vitro assays. Compounds 1, 2, 16, 17, 18, 27, 28 and 29 have better anti-tumor activities against MCF-7 and A549 cancer cell lines than 25-OH-PPD, together with low toxicity in the normal cell. The results may provide useful data for researching and developing new antitumor agents.
Insights
Thirty novel compounds derived from 25-hydroxyprotopanaxadiol (25-OH-PPD) were evaluated for their antitumor potential. Compound 27 demonstrated the most potent in vitro anticancer activity, with several analogs showing improved efficacy and reduced toxicity.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Cancer Research
Background:
- 25-hydroxyprotopanaxadiol (25-OH-PPD) is a precursor for novel compound synthesis.
- Developing effective and low-toxicity antitumor agents remains a critical challenge in cancer therapy.
Purpose of the Study:
- To synthesize novel compounds from 25-OH-PPD.
- To evaluate the in vitro antitumor activities of these novel compounds against various cancer cell lines.
- To identify lead compounds with enhanced anticancer efficacy and low toxicity.
Main Methods:
- Synthesis of 30 novel compounds from 25-OH-PPD.
- In vitro antitumor activity assessment using the MTT assay.
- Testing against three human cancer cell lines (MCF-7, A549) and one normal cell line (IOSE144).
Main Results:
- Compound 27 exhibited the strongest in vitro antitumor activity.
- Compounds 1, 2, 16, 17, 18, 27, 28, and 29 showed superior antitumor effects against MCF-7 and A549 cells compared to 25-OH-PPD.
- These promising compounds also demonstrated low toxicity to the normal IOSE144 cell line.
Conclusions:
- The synthesized novel compounds, particularly compound 27 and a subset of analogs, possess significant in vitro antitumor potential.
- These findings offer valuable data for the future development of novel anticancer drugs.
- The study highlights the therapeutic promise of 25-OH-PPD derivatives in cancer treatment.
